Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
The American Journal of Gastroenterology|February 1, 1996
Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter studyJ B Raskin, R H White, R Jaszewski, et al.Anesthesia and Analgesia|May 25, 2004
Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgeryTong J Gan, Girish P Joshi, Eugene Viscusi, et al.Clinical Therapeutics|March 25, 1999
Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the kneeS Z Zhao, S D Dedhiya, T S Bocanegra, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Classifying Clinical Trial Eligibility Criteria to Facilitate Phased Cohort Identification Using Clinical Data RepositoriesAmy Y Wang, William J Lancaster, Matthew C Wyatt, et al.Journal of the National Medical Association|December 13, 2005
Impact of a two-city community cancer prevention intervention on African AmericansDaniel S Blumenthal, Jane G Fort, Nasar U Ahmed, et al.The Journal of Biological Chemistry|May 4, 2011
In vitro motility of liver connexin vesicles along microtubules utilizes kinesin motorsAlfredo G Fort, John W Murray, Nadine Dandachi, et al.Nature Protocols|May 10, 2007
Transfection of mammalian cells with connexins and measurement of voltage sensitivity of their gap junctionsCristiane del Corsso, Miduturu Srinivas, Marcia Urban-Maldonado, et al.Cardiovascular Therapeutics|January 5, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI RiskJay L Goldstein, David J Whellan, James M Scheiman, et al.The American Journal of Medicine|October 1, 1992
Causes of death in persons with human immunodeficiency virus infectionM Stein, P O'Sullivan, T Wachtel, et al.American Journal of Obstetrics and Gynecology|April 22, 2006
A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomyThomas J Herzog, Robert L Coleman, James P Guerrieri, et al.Pageof 8